Publication | Open Access

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

UrologyMedicineVaccine TargetImmunologyTherapeutic VaccineImmunotherapeuticsPoxviral VaccineProstatic DiseaseImmunotherapyOncologyPhase 1Prostate-specific Antigen